Research on the relationships between pancreatic cancer and hyperglycemia in Chinese populations

Journal of Diabetes Investigation

Volumn 4, Issue 1, 2013, Pages 45-52

  Huang, Shan ^a   Ye, Hongying ^a   Wu, Wei ^a   Chen, Cheng ^a   Li, Ji ^a   Fu, Deliang ^a   Li, Yiming ^a  

^a FUDAN UNIVERSITY   (China)

Author keywords

Diabetes duration; Pancreatic cancer; Risk factors

Indexed keywords

GLUCOSE; TUMOR MARKER;

ADULT; AGED; ALCOHOL CONSUMPTION; ARTICLE; CANCER DIAGNOSIS; CANCER SURGERY; CHINESE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE DURATION; FEMALE; GLUCOSE METABOLISM; HISTOPATHOLOGY; HUMAN; HYPERGLYCEMIA; MAJOR CLINICAL STUDY; MALE; PANCREAS CANCER; PATHOGENESIS; PREVALENCE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SMOKING; TUMOR DIFFERENTIATION;

EID: 84873192190     PISSN: 20401116     EISSN: 20401124     Source Type: Journal    
DOI: 10.1111/j.2040-1124.2012.00237.x     Document Type: Article

References (21)

1. Everhart J, Wright D. Diabetes mellitus as a risk factor for pancreatic cancer. A meta-analysis. JAMA 1995; 273: 1605-1609.
2. Huxley R, Ansary-Moghaddam A, Berrington DGA, et al. Type-II diabetes and pancreatic cancer: a meta-analysis of 36 studies. Br J Cancer 2005; 92: 2076-2083.
3. Pannala R, Leirness JB, Bamlet WR, et al. Prevalence and clinical profile of pancreatic cancer-associated diabetes mellitus. Gastroenterology 2008; 134: 981-987.
4. Chari ST, Leibson CL, Rabe KG, et al. Pancreatic cancer-associated diabetes mellitus: prevalence and temporal association with diagnosis of cancer. Gastroenterology 2008; 134: 95-101.
5. Permert J, Ihse I, Jorfeldt L, et al. Improved glucose metabolism after subtotal pancreatectomy for pancreatic cancer. Br J Surg 1993; 80: 1047-1050.
6. Pannala R, Leibson CL, Rabe KG, et al. Temporal association of changes in fasting blood glucose and body mass index with diagnosis of pancreatic cancer. Am J Gastroenterol 2009; 104: 2318-2325.
7. Ben Q, Cai Q, Li Z, et al. The relationship between new-onset diabetes mellitus and pancreatic cancer risk: a case-control study. Eur J Cancer 2011; 47: 248-254.
8. Pannala R, Basu A, Petersen GM, et al. New-onset diabetes: a potential clue to the early diagnosis of pancreatic cancer. Lancet Oncol 2009; 10: 88-95.
9. Pelaez-Luna M, Takahashi N, Fletcher JG, et al. Resectability of presymptomatic pancreatic cancer and its relationship to onset of diabetes: a retrospective review of CT scans and fasting glucose values prior to diagnosis. Am J Gastroenterol 2007; 102: 2157-2163.
10. Gangi S, Fletcher JG, Nathan MA, et al. Time interval between abnormalities seen on CT and the clinical diagnosis of pancreatic cancer: retrospective review of CT scans obtained before diagnosis. AJR Am J Roentgenol 2004; 182: 897-903.
11. Gonzalez MJ, Truan AN, Turienzo E, et al. Epidemiology of exocrine pancreatic cancer in the Principality of Asturias, 1973-1992. Rev Esp Enferm Dig 1995; 87: 653-657.
12. Gudjonsson B, Livstone EM, Spiro HM. Cancer of the pancreas: diagnostic accuracy and survival statistics. Cancer 1978; 42: 2494-2506.
13. Hamilton SR, Aaltonen LE. World Health Organization Classification of Tumors. Pathology and Genetics of Tumours of the Digestive System. IARC Press, Lyon, 2000.
14. Dolan RV, ReMine WH, Dockerty MB. The fate of heterotopic pancreatic tissue. A study of 212 cases. Arch Surg 1974; 109: 762-765.
15. Feldman M, Weinberg T. Aberrant pancreas: a cause of duodenal syndrome. JAMA 1952; 148: 893-898.
16. Tsuchiya R, Noda T, Harada N, et al. Collective review of small carcinomas of the pancreas. Ann Surg 1986; 203: 77-81.
17. Basso D, Brigato L, Veronesi A, et al. The pancreatic cancer cell line MIA PaCa2 produces one or more factors able to induce hyperglycemia in SCID mice. Anticancer Res 1995; 15: 2585-2588.
18. Wang F, Larsson J, Abdiu A, et al. Dissociated secretion of islet amyloid polypeptide and insulin in serum-free culture media conditioned by human pancreatic adenocarcinoma cell lines. Int J Pancreatol 1997; 21: 157-164.
19. Wang F, Larsson J, Adrian TE, et al. In vitro influences between pancreatic adenocarcinoma cells and pancreatic islets. J Surg Res 1998; 79: 13-19.
20. Katsumichi I, Pour PM. Diabetes mellitus in pancreatic cancer: is it a causal relationship? Am J Surg 2007; 194: S71-S75.
21. Fogar P, Basso D, Pasquali C, et al. Portal but not peripheral serum levels of interleukin 6 could interfere with glucose metabolism in patients with pancreatic cancer. Clin Chim Acta 1998; 277: 181-189.